115 related articles for article (PubMed ID: 19100834)
1. Unaltered levels of transplant arteriosclerosis in the absence of the B cell homing chemokine receptor CXCR5.
Ensminger SM; Abele-Ohl S; Ohl L; Spriewald BM; Ramsperger-Gleixner M; Weyand M; Förster R
Transpl Immunol; 2009 Mar; 20(4):218-23. PubMed ID: 19100834
[TBL] [Abstract][Full Text] [Related]
2. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
[TBL] [Abstract][Full Text] [Related]
3. Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3.
Ensminger SM; Helm SN; Ohl L; Spriewald BM; Abele S; Wollin M; Wood KJ; Weyand M; Förster R
Transplantation; 2008 Aug; 86(4):590-600. PubMed ID: 18724230
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts.
Ensminger SM; Spriewald BM; Witzke O; Morrison K; Pajaro OE; Morris PJ; Rose ML; Wood KJ
Transplantation; 2002 Apr; 73(7):1068-74. PubMed ID: 11965033
[TBL] [Abstract][Full Text] [Related]
5. Platelet-endothelial cell adhesion molecule-1 (CD31) expression on donor endothelial cells attenuates the development of transplant arteriosclerosis.
Ensminger SM; Spriewald BM; Steger U; Morris PJ; Mak TW; Wood KJ
Transplantation; 2002 Nov; 74(9):1267-73. PubMed ID: 12451264
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CXCR5 supports solitary intestinal lymphoid tissue formation, B cell homing, and induction of intestinal IgA responses.
Velaga S; Herbrand H; Friedrichsen M; Jiong T; Dorsch M; Hoffmann MW; Förster R; Pabst O
J Immunol; 2009 Mar; 182(5):2610-9. PubMed ID: 19234155
[TBL] [Abstract][Full Text] [Related]
7. Antibody-suppressor CD8+ T Cells Require CXCR5.
Zimmerer JM; Ringwald BA; Elzein SM; Avila CL; Warren RT; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2019 Sep; 103(9):1809-1820. PubMed ID: 30830040
[TBL] [Abstract][Full Text] [Related]
8. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
Wiener A; Schippers A; Wagner N; Tacke F; Ostendorf T; Honke N; Tenbrock K; Ohl K
Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531
[TBL] [Abstract][Full Text] [Related]
9. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.
Sáez de Guinoa J; Barrio L; Mellado M; Carrasco YR
Blood; 2011 Aug; 118(6):1560-9. PubMed ID: 21659539
[TBL] [Abstract][Full Text] [Related]
10. Physical exercise reduces transplant arteriosclerosis in a mouse aorta transplantation model.
Sommer W; Knöfel AK; Izykowski N; Oldhafer F; Avsar M; Jonigk D; Warnecke G; Haverich A
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):330-7. PubMed ID: 25524687
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of transplant arteriosclerosis with clopidogrel is associated with a reduction of infiltrating dendritic cells and macrophages in murine aortic allografts.
Abele S; Spriewald BM; Ramsperger-Gleixner M; Wollin M; Hiemann NE; Nieswandt B; Weyand M; Ensminger SM
Transplantation; 2009 Jan; 87(2):207-16. PubMed ID: 19155974
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis.
Lee PC; Wang ZL; Qian S; Watkins SC; Lizonova A; Kovesdi I; Tzeng E; Simmons RL; Billiar TR; Shears LL
Transplantation; 2000 Mar; 69(6):1186-92. PubMed ID: 10762225
[TBL] [Abstract][Full Text] [Related]
13. Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cells.
Ensminger SM; Spriewald BM; Witzke O; Morrison K; van Maurik A; Morris PJ; Rose ML; Wood KJ
Transplantation; 2000 Sep; 70(6):955-63. PubMed ID: 11014649
[TBL] [Abstract][Full Text] [Related]
14. Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model.
Heim C; Bernhardt W; Jalilova S; Wang Z; Motsch B; Ramsperger-Gleixner M; Burzlaff N; Weyand M; Eckardt KU; Ensminger SM
Interact Cardiovasc Thorac Surg; 2016 May; 22(5):561-70. PubMed ID: 26819270
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ
Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761
[TBL] [Abstract][Full Text] [Related]
16. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.
Breitfeld D; Ohl L; Kremmer E; Ellwart J; Sallusto F; Lipp M; Förster R
J Exp Med; 2000 Dec; 192(11):1545-52. PubMed ID: 11104797
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of TNF-alpha reduces transplant arteriosclerosis in a murine aortic transplant model.
Wollin M; Abele S; Bruns H; Weyand M; Kalden JR; Ensminger SM; Spriewald BM
Transpl Int; 2009 Mar; 22(3):342-9. PubMed ID: 19055619
[TBL] [Abstract][Full Text] [Related]
18. Spin90 deficiency increases CXCL13-mediated B cell migration.
Park SH; Kim HR; Jun CD; Song WK; Park SG
Scand J Immunol; 2014 Sep; 80(3):191-7. PubMed ID: 24965518
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of B-cell non-Hodgkin lymphoma by targeting the chemokine receptor CXCR5 in a preclinical mouse model.
Panjideh H; Müller G; Koch M; Wilde F; Scheu S; Moldenhauer G; Lipp M
Int J Cancer; 2014 Dec; 135(11):2623-32. PubMed ID: 24729415
[TBL] [Abstract][Full Text] [Related]
20. Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
Haran KP; Hajduczki A; Pampusch MS; Mwakalundwa G; Vargas-Inchaustegui DA; Rakasz EG; Connick E; Berger EA; Skinner PJ
Front Immunol; 2018; 9():492. PubMed ID: 29616024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
